ScoreWhy is Porton Pharma Solutions Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 11.90% and Operating profit at -49.75% over the last 5 years
2
With a growth in Net Sales of 19.44%, the company declared Outstanding results in Sep 25
- RAW MATERIAL COST(Y) Fallen by -5.89% (YoY)
- NET SALES(Q) Highest at CNY 923.49 MM
- PRE-TAX PROFIT(Q) Highest at CNY 44.76 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 18.87%, its profits have risen by 59.7%
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Porton Pharma Solutions Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Porton Pharma Solutions Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Porton Pharma Solutions Ltd.
15.86%
0.85
52.10%
China Shanghai Composite
15.17%
1.02
14.86%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.90%
EBIT Growth (5y)
-49.75%
EBIT to Interest (avg)
26.30
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.50
Tax Ratio
14.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.03%
ROE (avg)
11.26%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.53
EV to EBIT
-291.26
EV to EBITDA
44.98
EV to Capital Employed
2.48
EV to Sales
4.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.85%
ROE (Latest)
-3.03%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -5.89% (YoY
NET SALES(Q)
Highest at CNY 923.49 MM
PRE-TAX PROFIT(Q)
Highest at CNY 44.76 MM
NET PROFIT(Q)
Highest at CNY 53.59 MM
EPS(Q)
Highest at CNY 0.1
-2What is not working for the Company
OPERATING PROFIT(Q)
Lowest at CNY 44.02 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 4.77 %
Here's what is working for Porton Pharma Solutions Ltd.
Net Profit
At CNY 53.59 MM has Grown at 246.57%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Pre-Tax Profit
At CNY 44.76 MM has Grown at 194.52%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Sales
Highest at CNY 923.49 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 44.76 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 53.59 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.1
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -5.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Porton Pharma Solutions Ltd.
Operating Profit
Lowest at CNY 44.02 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 4.77 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
